Skip to main content
Top
Published in: Virology Journal 1/2016

Open Access 01-12-2016 | Short report

Self-assembly of hexahistidine-tagged tobacco etch virus capsid protein into microfilaments that induce IgG2-specific response against a soluble porcine reproductive and respiratory syndrome virus chimeric protein

Authors: Carlos Alberto Manuel-Cabrera, Alba Adriana Vallejo-Cardona, Eduardo Padilla-Camberos, Rodolfo Hernández-Gutiérrez, Sara Elisa Herrera-Rodríguez, Abel Gutiérrez-Ortega

Published in: Virology Journal | Issue 1/2016

Login to get access

Abstract

Background

Assembly of recombinant capsid proteins into virus-like particles (VLPs) still represents an interesting challenge in virus-based nanotechnologies. The structure of VLPs has gained importance for the development and design of new adjuvants and antigen carriers. The potential of Tobacco etch virus capsid protein (TEV CP) as adjuvant has not been evaluated to date.

Findings

Two constructs for TEV CP expression in Escherichia coli were generated: a wild-type version (TEV-CP) and a C-terminal hexahistidine (His)-tagged version (His-TEV-CP). Although both versions were expressed in the soluble fraction of E. coli lysates, only His-TEV-CP self-assembled into micrometric flexuous filamentous VLPs. In addition, the His-tag enabled high yields and facilitated purification of TEV VLPs. These TEV VLPs elicited broader IgG2-specific antibody response against a novel porcine reproductive and respiratory syndrome virus (PRRSV) protein when compared to the potent IgG1 response induced by the protein alone.

Conclusions

His-TEV CP was purified by immobilized metal affinity chromatography and assembled into VLPs, some of them reaching 2-μm length. TEV VLPs administered along with PRRSV chimeric protein changed the IgG2/IgG1 ratio against the chimeric protein, suggesting that TEV CP can modulate the immune response against a soluble antigen.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vicente T, Roldão A, Peixoto C, Carrondo MJT, Alves PM. Large-scale production and purification of VLP-based vaccine. J Invertebr Pathol. 2011;107:S42–8.CrossRefPubMed Vicente T, Roldão A, Peixoto C, Carrondo MJT, Alves PM. Large-scale production and purification of VLP-based vaccine. J Invertebr Pathol. 2011;107:S42–8.CrossRefPubMed
2.
go back to reference Jennings GT, Bachmann MF. The coming of age of virus-like particle vaccines. J Biol Chem. 2008;389(5):521–36. Jennings GT, Bachmann MF. The coming of age of virus-like particle vaccines. J Biol Chem. 2008;389(5):521–36.
3.
go back to reference Zeltins A. Construction and Characterization of Virus-Like Particles: A Review. Mol Biotechnol. 2013;53:92–107.CrossRefPubMed Zeltins A. Construction and Characterization of Virus-Like Particles: A Review. Mol Biotechnol. 2013;53:92–107.CrossRefPubMed
4.
go back to reference Plummer EM, Manchester M. Viral nanoparticles and virus-like particles: Platforms for contemporary vaccine design. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3(2):174–96.CrossRefPubMed Plummer EM, Manchester M. Viral nanoparticles and virus-like particles: Platforms for contemporary vaccine design. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3(2):174–96.CrossRefPubMed
5.
go back to reference Manuel-Cabrera CA, Márquez-Aguirre A, Rodolfo HG, Ortiz-Lazareno PC, Chavez-Calvillo G, Carrillo-Tripp M, Silva-Rosales L, Gutiérrez-Ortega A. Immune response to a potyvirus with exposed amino groups available for chemical conjugation. Virol J. 2012;9:75.CrossRefPubMedPubMedCentral Manuel-Cabrera CA, Márquez-Aguirre A, Rodolfo HG, Ortiz-Lazareno PC, Chavez-Calvillo G, Carrillo-Tripp M, Silva-Rosales L, Gutiérrez-Ortega A. Immune response to a potyvirus with exposed amino groups available for chemical conjugation. Virol J. 2012;9:75.CrossRefPubMedPubMedCentral
7.
go back to reference Jagadish MN, Edwards SJ, Hayden MB, Grusovin J, Vandenberg K, Schoofs P, Hamilton RC, Shukla DD, Kalnins H, McNamara M, Haynes J, Nisbet IT, Ward CW, Pye D. Chimeric potyvirus-like particles as vaccine carriers. Intervirology. 1996;39(1-2):85–92.PubMed Jagadish MN, Edwards SJ, Hayden MB, Grusovin J, Vandenberg K, Schoofs P, Hamilton RC, Shukla DD, Kalnins H, McNamara M, Haynes J, Nisbet IT, Ward CW, Pye D. Chimeric potyvirus-like particles as vaccine carriers. Intervirology. 1996;39(1-2):85–92.PubMed
8.
go back to reference Jagadish MN, Ward CW, Gough KH, Tulloch PA, Whittaker LA, Shukla DD. Expression of potyvirus coat protein in Escherichia coli and yeast and its assembly into virus-like particles. J Gen Virol. 1991;72:1543–50.CrossRefPubMed Jagadish MN, Ward CW, Gough KH, Tulloch PA, Whittaker LA, Shukla DD. Expression of potyvirus coat protein in Escherichia coli and yeast and its assembly into virus-like particles. J Gen Virol. 1991;72:1543–50.CrossRefPubMed
9.
go back to reference Stram Y, Sela I, Edelbaum O, Tanne E, Karchi M, Karchi H. Expression and assembly of the potato virus Y (PVY) coat protein (CP) in Escherichia coli cells. Virus Res. 1993;28:29–35.CrossRefPubMed Stram Y, Sela I, Edelbaum O, Tanne E, Karchi M, Karchi H. Expression and assembly of the potato virus Y (PVY) coat protein (CP) in Escherichia coli cells. Virus Res. 1993;28:29–35.CrossRefPubMed
10.
go back to reference Jacquet C, Delecolle B, Raccah B, Lecoq H, Dunez J, Ravelonandro M. Use of modified plum pox virus coat protein genes developed to limit heteroencapsidation-associated risks in transgenic plants. J Gen Virol. 1998;79(Pt 6):1509–17.CrossRefPubMed Jacquet C, Delecolle B, Raccah B, Lecoq H, Dunez J, Ravelonandro M. Use of modified plum pox virus coat protein genes developed to limit heteroencapsidation-associated risks in transgenic plants. J Gen Virol. 1998;79(Pt 6):1509–17.CrossRefPubMed
11.
go back to reference Joseph J, Savithri HS. Determination of 3′-terminal nucleotide sequence of pepper vein banding virus RNA and expression of its coat protein in Escherichia coli. Arch Virol. 1999;144(9):1679–87.CrossRefPubMed Joseph J, Savithri HS. Determination of 3′-terminal nucleotide sequence of pepper vein banding virus RNA and expression of its coat protein in Escherichia coli. Arch Virol. 1999;144(9):1679–87.CrossRefPubMed
12.
go back to reference Chatchen S, Jurícek M, Rueda P, Kertbundit S. Papaya Ringspot Virus Coat Protein Gene for Antigen Presentation in Escherichia coli. J Biochem Mol Biol. 2006;39(1):16–21.PubMed Chatchen S, Jurícek M, Rueda P, Kertbundit S. Papaya Ringspot Virus Coat Protein Gene for Antigen Presentation in Escherichia coli. J Biochem Mol Biol. 2006;39(1):16–21.PubMed
13.
go back to reference Voloudakis E, Malpica CA, Aleman-Verdaguer ME, Stark DM, Fauquet CM, Beachy RN. Structural characterization of Tobacco etch virus coat protein mutants. Arch Virol. 2004;149:699–712.CrossRefPubMed Voloudakis E, Malpica CA, Aleman-Verdaguer ME, Stark DM, Fauquet CM, Beachy RN. Structural characterization of Tobacco etch virus coat protein mutants. Arch Virol. 2004;149:699–712.CrossRefPubMed
14.
go back to reference Guerrero-Rodríguez J, Manuel-Cabrera CA, Palomino-Hermosillo YA, Delgado-Guzmán PG, Escoto-Delgadillo M, Silva-Rosales L, Herrera-Rodríguez SE, Sánchez-Hernández C, Gutiérrez-Ortega A. Virus-Like Particles from Escherichia coli-Derived Untagged Papaya Ringspot Virus Capsid Protein Purified by Immobilized Metal Affinity Chromatography Enhance the Antibody Response Against a Soluble Antigen. Mol Biotechnol. 2014;56(12):1110–20.CrossRefPubMed Guerrero-Rodríguez J, Manuel-Cabrera CA, Palomino-Hermosillo YA, Delgado-Guzmán PG, Escoto-Delgadillo M, Silva-Rosales L, Herrera-Rodríguez SE, Sánchez-Hernández C, Gutiérrez-Ortega A. Virus-Like Particles from Escherichia coli-Derived Untagged Papaya Ringspot Virus Capsid Protein Purified by Immobilized Metal Affinity Chromatography Enhance the Antibody Response Against a Soluble Antigen. Mol Biotechnol. 2014;56(12):1110–20.CrossRefPubMed
15.
go back to reference Kalnciema I, Balke I, Skrastina D, Ose V, Zeltins A. Potato Virus M-Like Nanoparticles: Construction and Characterization. Mol Biotechnol. 2015;57(11-12):982–92.CrossRefPubMed Kalnciema I, Balke I, Skrastina D, Ose V, Zeltins A. Potato Virus M-Like Nanoparticles: Construction and Characterization. Mol Biotechnol. 2015;57(11-12):982–92.CrossRefPubMed
16.
go back to reference Willson RC, Murphy JC. Nucleic acid separation using immobilized metal affinity chromatography. US patent publication number US. 2004;20040152076:A1. Willson RC, Murphy JC. Nucleic acid separation using immobilized metal affinity chromatography. US patent publication number US. 2004;20040152076:A1.
17.
go back to reference Visciano ML, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L. Effects of adjuvants on IgG subclasses elicited by virus-like particles. J Transl Med. 2012;10(4):1–8. Visciano ML, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L. Effects of adjuvants on IgG subclasses elicited by virus-like particles. J Transl Med. 2012;10(4):1–8.
18.
go back to reference Bruckman MA, Soto CM, McDowell H, Liu JL, Ratna BR, Korpany KV, Zahr OK, Blum AS. Role of Hexahistidine in Directed Nanoassemblies of Tobacco Mosaic Virus Coat Protein. ACSNano. 2011;5(3):1606–16. Bruckman MA, Soto CM, McDowell H, Liu JL, Ratna BR, Korpany KV, Zahr OK, Blum AS. Role of Hexahistidine in Directed Nanoassemblies of Tobacco Mosaic Virus Coat Protein. ACSNano. 2011;5(3):1606–16.
19.
go back to reference Ratna BR, Blum AS, Soto CM, Bruckman MA, Liu JL, Rendell RW, Long JP, Tonucci RJ. Metamaterial optical elements self-assembled on protein scaffolds. US patent publication number US. 2014;20148831386:B2. Ratna BR, Blum AS, Soto CM, Bruckman MA, Liu JL, Rendell RW, Long JP, Tonucci RJ. Metamaterial optical elements self-assembled on protein scaffolds. US patent publication number US. 2014;20148831386:B2.
20.
go back to reference Khan F, Legler PM, Mease RM, Duncan EH, Bergmann-Leitner ES, Angov E. Histidine affinity tags affect MSP1(42) structural stability and immunodominance in mice. Biotechnol J. 2012;7(1):133–47.CrossRefPubMed Khan F, Legler PM, Mease RM, Duncan EH, Bergmann-Leitner ES, Angov E. Histidine affinity tags affect MSP1(42) structural stability and immunodominance in mice. Biotechnol J. 2012;7(1):133–47.CrossRefPubMed
21.
go back to reference Markine-Goriaynoff D, van der Logt JT, Truyens C, Nguyen TD, Heessen FW, Bigaignon G, Carlier Y, Coutelier JP. IFN-gamma-independent IgG2a production in mice infected with viruses and parasites. Int Immunol. 2012;12(2):223–30.CrossRef Markine-Goriaynoff D, van der Logt JT, Truyens C, Nguyen TD, Heessen FW, Bigaignon G, Carlier Y, Coutelier JP. IFN-gamma-independent IgG2a production in mice infected with viruses and parasites. Int Immunol. 2012;12(2):223–30.CrossRef
22.
go back to reference Savard C, Guérin A, Drouin K, Bolduc M, Laliberté Gagné M-E, Dumas MC, Majeau N, Leclerc D. Improvement of the trivalent inactivated Flu vaccine using PapMV nanoparticles. PLoS One. 2011;6(6), e21522.CrossRefPubMedPubMedCentral Savard C, Guérin A, Drouin K, Bolduc M, Laliberté Gagné M-E, Dumas MC, Majeau N, Leclerc D. Improvement of the trivalent inactivated Flu vaccine using PapMV nanoparticles. PLoS One. 2011;6(6), e21522.CrossRefPubMedPubMedCentral
23.
go back to reference Yu M, Qiu Y, Chen J, Jiang W. Enhanced humoral and cellular immune responses to PRRS virus GP5 glycoprotein by DNA prime-adenovirus boost vaccination in mice. Virus Genes. 2016;52(2):228–34.CrossRefPubMed Yu M, Qiu Y, Chen J, Jiang W. Enhanced humoral and cellular immune responses to PRRS virus GP5 glycoprotein by DNA prime-adenovirus boost vaccination in mice. Virus Genes. 2016;52(2):228–34.CrossRefPubMed
24.
go back to reference Kalnciema K, Skrastina D, Ose V, Pumpens P, Zeltins A. Potato Virus Y-Like Particles as a New Carrier for the Presentation of Foreign Protein Stretches. Mol Biotechnol. 2012;52(2):129–39.CrossRefPubMed Kalnciema K, Skrastina D, Ose V, Pumpens P, Zeltins A. Potato Virus Y-Like Particles as a New Carrier for the Presentation of Foreign Protein Stretches. Mol Biotechnol. 2012;52(2):129–39.CrossRefPubMed
25.
go back to reference Oyewumi MO, Kumar A, Cui Z. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev Vaccines. 2010;9(9):1095–107.CrossRefPubMedPubMedCentral Oyewumi MO, Kumar A, Cui Z. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev Vaccines. 2010;9(9):1095–107.CrossRefPubMedPubMedCentral
Metadata
Title
Self-assembly of hexahistidine-tagged tobacco etch virus capsid protein into microfilaments that induce IgG2-specific response against a soluble porcine reproductive and respiratory syndrome virus chimeric protein
Authors
Carlos Alberto Manuel-Cabrera
Alba Adriana Vallejo-Cardona
Eduardo Padilla-Camberos
Rodolfo Hernández-Gutiérrez
Sara Elisa Herrera-Rodríguez
Abel Gutiérrez-Ortega
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2016
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-016-0651-y

Other articles of this Issue 1/2016

Virology Journal 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.